Vivek Ramaswamy is 10% Owner at Roivant Sciences Ltd. (ROIV). They have made 8 open-market trades across 1 company since 2023, most recently 2025-12-15.
CIK 0001635075
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases since 2025, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ROIV | 36,350,621 | $1.2B |
| ASST | 15,625 | $376K |
| Total | $1.2B |
Shares reported on the most recent Form 4, priced at the 2025-12-15 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 14% | 43% | 0% |
| Avg Move | +2.6% | +4.4% | +24.6% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ROIV | SELL | 2025-12-11 | 2025-12-15 | $21.89 | $135.9M | +1.7% | +9.0% | +29.4% |
| ROIV | SELL | 2025-11-13 | 2025-11-17 | $20.46 | $75.9M | +1.8% | +11.1% | +32.5% |
| ROIV | SELL | 2025-09-03 | 2025-09-05 | $12.72 | $30.0M | +18.4% | +26.0% | +64.2% |
| ROIV | SELL | 2025-06-18 | 2025-06-23 | $11.46 | $26.2M | -5.2% | -1.7% | +28.9% |
| ROIV | SELL | 2025-06-04 | 2025-06-06 | $11.32 | $14.7M | +1.1% | -5.1% | +11.0% |
| ROIV | SELL | 2025-05-06 | 2025-05-08 | $11.32 | $13.3M | +0.0% | +0.4% | +5.5% |
| ROIV | SELL | 2024-01-02 | 2024-01-03 | $11.05 | $66.3M | +0.0% | -8.9% | +0.6% |
| ROIV | SELL | 2023-02-22 | 2023-02-22 | $7.95 | $31.8M | -4.0% | -15.6% | +14.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.